DEXTROMETHORPHAN O-DEMETHYLATION IN LIVER-MICROSOMES AS A PROTOTYPE REACTION TO MONITOR CYTOCHROME-P-450 DB1 ACTIVITY

被引：129

作者：

DAYER, P

LEEMANN, T

STRIBERNI, R

机构：

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1989年 / 45卷 / 01期

关键词：

D O I：

10.1038/clpt.1989.6

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：34 / 40

页数：7

共 31 条

[1] IMPORTANCE OF OXIDATIVE POLYMORPHISM AND LEVOMEPROMAZINE TREATMENT ON THE STEADY-STATE BLOOD-CONCENTRATIONS OF CLOMIPRAMINE AND ITS MAJOR METABOLITES [J].

BALANTGORGIA, AE ;

BALANT, LP ;

GENET, C ;

DAYER, P ;

AESCHLIMANN, JM ;

GARRONE, G .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 31 (04) :449-455

[2] NORTRIPTYLINE AND ANTIPYRINE CLEARANCE IN RELATION TO DEBRISOQUINE HYDROXYLATION IN MAN [J].

BERTILSSON, L ;

EICHELBAUM, M ;

MELLSTROM, B ;

SAWE, J ;

SCHULZ, HU ;

SJOQVIST, F .

LIFE SCIENCES, 1980, 27 (18) :1673-1677

[3] GENETIC-POLYMORPHISM IN DRUG OXIDATION - INVITRO STUDIES OF HUMAN DEBRISOQUINE 4-HYDROXYLASE AND BUFURALOL 1'-HYDROXYLASE ACTIVITIES [J].

BOOBIS, AR ;

MURRAY, S ;

HAMPDEN, CE ;

DAVIES, DS .

BIOCHEMICAL PHARMACOLOGY, 1985, 34 (01) :65-71

[4] GENETICALLY-DETERMINED VARIABILITY IN ACETYLATION AND OXIDATION - THERAPEUTIC IMPLICATIONS [J].

CLARK, DWJ .

DRUGS, 1985, 29 (04) :342-375

[5] EVIDENCE FOR AN ENZYMATIC DEFECT IN THE 4-HYDROXYLATION OF DEBRISOQUINE BY HUMAN-LIVER [J].

DAVIES, DS ;

KAHN, GC ;

MURRAY, S ;

BRODIE, MJ ;

BOOBIS, AR .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (01) :89-91

[6] CHARACTERIZATION OF A COMMON GENETIC-DEFECT OF CYTOCHROME-P-450 FUNCTION (DEBRISOQUINE-SPARTEINE TYPE POLYMORPHISM) - INCREASED MICHAELIS CONSTANT (KM) AND LOSS OF STEREOSELECTIVITY OF BUFURALOL 1'-HYDROXYLATION IN POOR METABOLIZERS [J].

DAYER, P ;

GASSER, R ;

GUT, J ;

KRONBACH, T ;

ROBERTZ, GM ;

EICHELBAUM, M ;

MEYER, UA .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 125 (01) :374-380

[7] ENZYMATIC BASIS OF THE DEBRISOQUINE SPARTEINE-TYPE GENETIC-POLYMORPHISM OF DRUG OXIDATION - CHARACTERIZATION OF BUFURALOL 1'-HYDROXYLATION IN LIVER-MICROSOMES OF INVIVO PHENOTYPED CARRIERS OF THE GENETIC DEFICIENCY [J].

DAYER, P ;

KRONBACH, T ;

EICHELBAUM, M ;

MEYER, UA .

BIOCHEMICAL PHARMACOLOGY, 1987, 36 (23) :4145-4152

[8] BIOACTIVATION OF THE NARCOTIC DRUG CODEINE IN HUMAN-LIVER IS MEDIATED BY THE POLYMORPHIC MONOOXYGENASE CATALYZING DEBRISOQUINE 4-HYDROXYLATION (CYTOCHROME-P-450 DBL/BUFI) [J].

DAYER, P ;

DESMEULES, J ;

LEEMANN, T ;

STRIBERNI, R .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 152 (01) :411-416

[9] DEFECTIVE HYDROXYLATION OF BUFURALOL ASSOCIATED WITH SIDE-EFFECTS OF THE DRUG IN POOR METABOLIZERS [J].

DAYER, P ;

KUBLI, A ;

KUPFER, A ;

COURVOISIER, F ;

BALANT, L ;

FABRE, J .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 (05) :750-752

[10] CHARACTERIZATION OF A HUMAN-LIVER CYTOCHROME-P-450 INVOLVED IN THE OXIDATION OF DEBRISOQUINE AND OTHER DRUGS BY USING ANTIBODIES RAISED TO THE ANALOGOUS RAT ENZYME [J].

DISTLERATH, LM ;

GUENGERICH, FP .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (23) :7348-7352

← 1 2 3 4 →